Cargando…

Burden of Acute Viral Hepatitis — China, 1990−2019

What is already known about this topic? The World Health Organization’s (WHO) Global Health Estimates (GHE) reported that acute hepatitis caused 9,213 deaths and 307,720 person years of disability-adjusted life years (DALYs) in 2016, and acute hepatitis B accounted for 85.81% of all DALYs among acut...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shicheng, Wang, Qiqi, Wang, Shujun, Zhang, Jiaojiao, Hu, Yuehua, Li, Junqi, Long, Xiaojuan, Xiang, Xianglong, Zhou, Maigeng, Tan, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428429/
https://www.ncbi.nlm.nih.gov/pubmed/34594713
http://dx.doi.org/10.46234/ccdcw2020.156
_version_ 1783750375495434240
author Yu, Shicheng
Wang, Qiqi
Wang, Shujun
Zhang, Jiaojiao
Hu, Yuehua
Li, Junqi
Long, Xiaojuan
Xiang, Xianglong
Zhou, Maigeng
Tan, Feng
author_facet Yu, Shicheng
Wang, Qiqi
Wang, Shujun
Zhang, Jiaojiao
Hu, Yuehua
Li, Junqi
Long, Xiaojuan
Xiang, Xianglong
Zhou, Maigeng
Tan, Feng
author_sort Yu, Shicheng
collection PubMed
description What is already known about this topic? The World Health Organization’s (WHO) Global Health Estimates (GHE) reported that acute hepatitis caused 9,213 deaths and 307,720 person years of disability-adjusted life years (DALYs) in 2016, and acute hepatitis B accounted for 85.81% of all DALYs among acute hepatitis types A, B, C, and E in China. What is added by this report? In China, the percent changes in years lived with disability (YLDs) due to acute hepatitis A, B, and E in groups aged 50–69 years and 70 years or more and in all age groups for acute hepatitis C were increased from 2000 to 2019. What are the implications for public health practices? Effective vaccines, interventions, and treatments are key approaches to achieve the WHO’s goal of reducing new hepatitis infections by 90% and deaths by 65% between 2016 and 2030.
format Online
Article
Text
id pubmed-8428429
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-84284292021-09-29 Burden of Acute Viral Hepatitis — China, 1990−2019 Yu, Shicheng Wang, Qiqi Wang, Shujun Zhang, Jiaojiao Hu, Yuehua Li, Junqi Long, Xiaojuan Xiang, Xianglong Zhou, Maigeng Tan, Feng China CDC Wkly Preplanned Studies What is already known about this topic? The World Health Organization’s (WHO) Global Health Estimates (GHE) reported that acute hepatitis caused 9,213 deaths and 307,720 person years of disability-adjusted life years (DALYs) in 2016, and acute hepatitis B accounted for 85.81% of all DALYs among acute hepatitis types A, B, C, and E in China. What is added by this report? In China, the percent changes in years lived with disability (YLDs) due to acute hepatitis A, B, and E in groups aged 50–69 years and 70 years or more and in all age groups for acute hepatitis C were increased from 2000 to 2019. What are the implications for public health practices? Effective vaccines, interventions, and treatments are key approaches to achieve the WHO’s goal of reducing new hepatitis infections by 90% and deaths by 65% between 2016 and 2030. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2020-07-31 /pmc/articles/PMC8428429/ /pubmed/34594713 http://dx.doi.org/10.46234/ccdcw2020.156 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2020 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Preplanned Studies
Yu, Shicheng
Wang, Qiqi
Wang, Shujun
Zhang, Jiaojiao
Hu, Yuehua
Li, Junqi
Long, Xiaojuan
Xiang, Xianglong
Zhou, Maigeng
Tan, Feng
Burden of Acute Viral Hepatitis — China, 1990−2019
title Burden of Acute Viral Hepatitis — China, 1990−2019
title_full Burden of Acute Viral Hepatitis — China, 1990−2019
title_fullStr Burden of Acute Viral Hepatitis — China, 1990−2019
title_full_unstemmed Burden of Acute Viral Hepatitis — China, 1990−2019
title_short Burden of Acute Viral Hepatitis — China, 1990−2019
title_sort burden of acute viral hepatitis — china, 1990−2019
topic Preplanned Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428429/
https://www.ncbi.nlm.nih.gov/pubmed/34594713
http://dx.doi.org/10.46234/ccdcw2020.156
work_keys_str_mv AT yushicheng burdenofacuteviralhepatitischina19902019
AT wangqiqi burdenofacuteviralhepatitischina19902019
AT wangshujun burdenofacuteviralhepatitischina19902019
AT zhangjiaojiao burdenofacuteviralhepatitischina19902019
AT huyuehua burdenofacuteviralhepatitischina19902019
AT lijunqi burdenofacuteviralhepatitischina19902019
AT longxiaojuan burdenofacuteviralhepatitischina19902019
AT xiangxianglong burdenofacuteviralhepatitischina19902019
AT zhoumaigeng burdenofacuteviralhepatitischina19902019
AT tanfeng burdenofacuteviralhepatitischina19902019